SEC Info - Rubius Therapeutics, Inc. - ‘S-3’ on 8/1/19

SEC Info℠

Home

Help

Please Sign In

Rubius Therapeutics, Inc. – ‘S-3’ on 8/1/19

On: Thursday, 8/1/19, at 5:19pm ET · Accession #: 1047469-19-4493 · File #: 333-232955

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/01/19  Rubius Therapeutics, Inc.         S-3                    7:1.7M                                   Merrill Corp/New/FA

Registration Statement for Securities Offered Pursuant to a Transaction — Form S-3
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-3         Registration Statement for Securities Offered       HTML    343K 
                Pursuant to a Transaction                                        
 2: EX-1.2      Underwriting Agreement                              HTML    253K 
 3: EX-4.3      Instrument Defining the Rights of Security Holders  HTML    325K 
 4: EX-4.4      Instrument Defining the Rights of Security Holders  HTML    309K 
 5: EX-5.1      Opinion of Counsel re: Legality                     HTML     19K 
 6: EX-5.2      Opinion of Counsel re: Legality                     HTML     13K 
 7: EX-23.1     Consent of Experts or Counsel                       HTML      6K

Filing Submission 0001047469-19-004493 – SGML Text

Original SGML Text submitted by:	Toppan Merrill-FA (as Filing Agent)

⇓Show all <DOCUMENT> <TEXT> elements below – 1.7M ↑Top ↓Bottom

<SUBMISSION>
<SECRELEASE-DATETIME>		20190801-162049	 ⇐ Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME>		20190801-162049	 ⇐ Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME>		20190801-171954	 ⇐ Filing accepted by SEC (ET)
<ACCESSION-NUMBER>		0001047469-19-004493
<TYPE>				S-3
<PUBLIC-DOCUMENT-COUNT>		10
<FILING-DATE>			20190801
<DATE-OF-FILING-DATE-CHANGE>	20190801

<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>		Rubius Therapeutics, Inc.
<CIK>				0001709401
<ASSIGNED-SIC>			2836
<IRS-NUMBER>			042688109  ⇒ 04-2688109 or 042-68-8109
<STATE-OF-INCORPORATION>	DE
<FISCAL-YEAR-END>		1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>			S-3
<ACT>				33
<FILE-NUMBER>			333-232955
<FILM-NUMBER>			19993634
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>			399 BINNEY STREET, SUITE 300
<CITY>				CAMBRIDGE
<STATE>				MA
<ZIP>				02139
<PHONE>				617-679-9600
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>			399 BINNEY STREET, SUITE 300
<CITY>				CAMBRIDGE
<STATE>				MA
<ZIP>				02139
</MAIL-ADDRESS>
</FILER>

<DOCUMENT>
<TYPE>		S-3
<SEQUENCE>	1
<FILENAME>	a2239379zs-3.htm
<DESCRIPTION>	S-3
<TEXT>
<HTML>
       Show <HTML>: 5,189 lines (widest: 311 characters) - 426K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-1.2
<SEQUENCE>	2
<FILENAME>	a2239379zex-1_2.htm
<DESCRIPTION>	EX-1.2
<TEXT>
<HTML>
       Show <HTML>: 1,508 lines (widest: 4,684 characters) - 347K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-4.3
<SEQUENCE>	3
<FILENAME>	a2239379zex-4_3.htm
<DESCRIPTION>	EX-4.3
<TEXT>
<HTML>
       Show <HTML>: 2,750 lines (widest: 2,933 characters) - 475K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-4.4
<SEQUENCE>	4
<FILENAME>	a2239379zex-4_4.htm
<DESCRIPTION>	EX-4.4
<TEXT>
<HTML>
       Show <HTML>: 2,603 lines (widest: 2,731 characters) - 431K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-5.1
<SEQUENCE>	5
<FILENAME>	a2239379zex-5_1.htm
<DESCRIPTION>	EX-5.1
<TEXT>
<HTML>
       Show <HTML>: 126 lines (widest: 1,796 characters) - 20K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-5.2
<SEQUENCE>	6
<FILENAME>	a2239379zex-5_2.htm
<DESCRIPTION>	EX-5.2
<TEXT>
<HTML>
       Show <HTML>: 99 lines (widest: 1,471 characters) - 13K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-23.1
<SEQUENCE>	7
<FILENAME>	a2239379zex-23_1.htm
<DESCRIPTION>	EX-23.1
<TEXT>
<HTML>
       Show <HTML>: 25 lines (widest: 578 characters) - 3K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	8  ⇐ Not a Document/Exhibit
<FILENAME>	g163162ksi001.jpg
<DESCRIPTION>	G163162KSI001.JPG
<TEXT>
       Show <TEXT>: 60 lines (Unix-to-Unix encoding) - 4K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	9  ⇐ Not a Document/Exhibit
<FILENAME>	g163162kui001.jpg
<DESCRIPTION>	G163162KUI001.JPG
<TEXT>
       Show <TEXT>: 60 lines (Unix-to-Unix encoding) - 4K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	10  ⇐ Not a Document/Exhibit
<FILENAME>	g146941.jpg
<DESCRIPTION>	G146941.JPG
<TEXT>
       Show <TEXT>: 439 lines (Unix-to-Unix encoding) - 27K bytes  
</TEXT>
</DOCUMENT>

</SUBMISSION>

↑Top

Filing Submission 0001047469-19-004493 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Rubius Therapeutics, Inc. – ‘S-3’ on 8/1/19

On: Thursday, 8/1/19, at 5:19pm ET · Accession #: 1047469-19-4493 · File #: 333-232955

Registration Statement for Securities Offered Pursuant to a Transaction — Form S-3Filing Table of Contents

Registration Statement for Securities Offered Pursuant to a Transaction — Form S-3
Filing Table of Contents